[Specific cellular immunity indices in acute leukemia in children]

Area of Science:

• Immunology
• Oncology
• Cellular Immunity

Background:

• Acute leukemia is a complex hematological malignancy.
• Understanding cell immunity in leukemia patients is crucial for treatment strategies.
• Immune cell function can be altered during different phases of the disease.

Purpose of the Study:

• To investigate cell immunity in acute leukemia patients.
• To compare immune responses with healthy donors.
• To analyze immune cell function during remission and recurrence.

Main Methods:

• Assessed lymphocyte cytotoxic reactions (killer cell function).
• Measured leucocyte adherence inhibition (antigen-reactive cell function).
• Compared patient responses to leukemia-associated antigens with healthy controls.

Main Results:

• Statistically significant enhancement in lymphocyte reactivity against leukemia-associated antigens in patients versus healthy donors.
• Increased cytotoxic activity of lymphocytes observed during complete remission and preceding recurrence.
• Reduced potential of antigen-reactive cells noted during complete remission and against the backdrop of recurrence.

Conclusions:

• Patients with acute leukemia exhibit altered cell immunity.
• Immune responses vary significantly between different disease phases (remission, recurrence).
• Further research into immune modulation may offer therapeutic benefits for acute leukemia.